Speakers
Arpan Desai
Managing Director
NanoVation Therapeutics
Day One
Wednesday 19th October 2022
8:30 am | Panel Discussion: Setting the Context – Current & Potential Uses of LNPs
Ben Knappett
Head of Science & Applications
Particle Works
Day One
Wednesday 19th October 2022
4:30 pm | Automated High-Throughput Screening of LNP Formulations
Edward Grahame
Field Application Scientist
Precision NanoSystems
Lu Tian
Director, CMC Project Management
STA Pharmaceutical
Day Two
Thursday 20th October 2022
11:30 am | Outlining Oligo Drug Delivery & LNP Platform at WuXi STA
Senior Representative
Knauer
Day Two
Thursday 20th October 2022
12:30 pm | Session Reserved for Knauer
Mostafa Nakach
Head of Formulation & Process Development
Sanofi
Day Two
Thursday 20th October 2022
2:15 pm | Scale Up of Nano-Drug Delivery Systems Manufacturing for Clinical Investigations
1:45 pm | Panel Discussion: Review the Challenges of Effectively Scaling LNPs
Shahid Uddin
Senior Director of Formulation & Stability
Mendus
Day Two
Thursday 20th October 2022
4:15 pm | Chair’s Closing Remarks & End of Summit
8:20 am | Chair’s Opening Remarks
Shashank Pinnapireddy
Head of Nanoparticle Research
CSL Behring
Day One
Wednesday 19th October 2022
8:30 am | Panel Discussion: Setting the Context – Current & Potential Uses of LNPs
Day Two
Thursday 20th October 2022
9:00 am | Roundtable Discussion: LNP Stability & Storage – Overcoming the Barriers
Sune Andersen
Principal Scientist in Particle Engineering
Janssen
Day Two
Thursday 20th October 2022
8:30 am | Advancing Methods to Address the Stability Challenge
Juliana Haggerty
Head of Center of Excellence – LNP
CPI
Day Two
Thursday 20th October 2022
1:45 pm | Panel Discussion: Review the Challenges of Effectively Scaling LNPs
12:00 pm | Accelerating Scale Up & GMP Manufacturing of LNPs
Dimitrios A. Lamprou
Professor (Chair) of Biofabrication and Advanced Manufacturing
Queen's University Belfast
Day Two
Thursday 20th October 2022
3:45 pm | Continuous & Scalable Manufacturing of LNPs by Microfluidics
Geoffrey Prevot
Formulation Project Manager
Servier
Day One
Wednesday 19th October 2022
4:45 pm | Delivering RNA to Neutrons In Vitro & In Vivo
1:45 pm | Panel Discussion: To the Liver & Beyond – Exploring Novel Delivery Areas
Sanyogitta Puri
Director
AstraZeneca
Day One
Wednesday 19th October 2022
5:15 pm | Chair’s Closing Remarks & End of Day One
8:20 am | Chair’s Opening Remarks
Day Two
Thursday 20th October 2022
9:45 am | Fireside Chat: Accelerating LNP Products into the Clinic - Beyond Vaccines
Zohreh Amoozgar
Principal Scientist
Sanofi
Day Two
Thursday 20th October 2022
9:45 am | Fireside Chat: Accelerating LNP Products into the Clinic - Beyond Vaccines
Pierre-Alexandre Driguez
Head of mRNA Platform - Vitry
Sanofi
Day One
Wednesday 19th October 2022
1:45 pm | Panel Discussion: To the Liver & Beyond – Exploring Novel Delivery Areas
Daniel L. Shores
Partner
Rothwell Figg
Day One
Wednesday 19th October 2022
11:45 am | Virtual Navigating the IP Landscape for LNP Delivery Technology
Driton Vllasaliu
Senior Lecturer in Pharmaceutics
Kings College London
Day One
Wednesday 19th October 2022
9:30 am | Alternative Systems for Mucosal Delivery of Nucleic Acids
Kristina Friis
Senior Scientist, Advanced Drug Delivery
AstraZeneca
Day One
Wednesday 19th October 2022
2:45 pm | Spray Drying of LNPs Enables Intratracheal Delivery of mRNA
8:30 am | Panel Discussion: Setting the Context – Current & Potential Uses of LNPs
Rob Worsham
Senior Director, Manufacturing Science & Technology
Insmed
Day Two
Thursday 20th October 2022
3:15 pm | Optimisation of Continuous Manufacturing for Liposomal Drug Products
Stephen Lock
Senior Market Development Manager
Biopharma EMEAI, SCIEX
Moein Moghimi
Professor
University of Newcastle
Day One
Wednesday 19th October 2022
9:00 am | Pro-Inflammatory Concerns Associated with LNPs
Ken Howard
Associate Professor
Aarhus University
Day One
Wednesday 19th October 2022
11:15 am | Biomolecular Oligonucleotide Assembles for Systemic Delivery of Therapeutic Nucleic Acids
10:00 am | Biomolecular Oligonucleotide Assembles for Systemic Delivery of Therapeutic Nucleic Acids
Nawel Khalef
Associate Professor
University of Joseph Fourier, Grenoble
Dai Hayward
CEO
Micropore Technologies Ltd.
Day One
Wednesday 19th October 2022
3:15 pm | Compliant Scalability of LNP Manufacture from Lab to 1 Billion Dose
Zongyi Li
Post-Doctoral Researcher
University of Manchester
Day One
Wednesday 19th October 2022
4:00 pm | Utilising Small-Angle Neutron Scattering (SANS) to Understand the Structure of LNPs
8:30 am | Panel Discussion: Setting the Context – Current & Potential Uses of LNPs
Nikolas N. Daskalakis
Senior Scientist, Advanced Drug Delivery
AstraZeneca
Edward Grahame
Field Application Scientist
Precision Nanosystems
Day One
Wednesday 19th October 2022
12:15 pm | GenVoy™ Lipid Nanoparticles: A Versatile Tool for Developing RNA Vaccines
Day Two
Thursday 20th October 2022